Mekhla Singhania, PhD, successfully defended her thesis "Enhancing Therapeutic Responses in NSCLC Using Pharmacological Ascorbate and Iron-Oxide Nanoparticles” in the Urmila Sahai Auditorium on July 8, 2024. She prepared her thesis under the mentorship of Douglas Spitz, PhD in whose lab she conducted the research supporting her work. Committee members included Bryan Allen, MBA, MD, PhD, Maria Spies, PhD, Garry Buettner, PhD and Prabhat Goswami, PhD. Mekhla will next complete a post-doctorate at the University of California in San Diego.